Maropitant

	WikiDoc Resources for Maropitant
Articles
Most recent articles on Maropitant Most cited articles on Maropitant Review articles on Maropitant Articles on Maropitant in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Maropitant Images of Maropitant Photos of Maropitant Podcasts & MP3s on Maropitant Videos on Maropitant
Evidence Based Medicine
Cochrane Collaboration on Maropitant Bandolier on Maropitant TRIP on Maropitant
Clinical Trials
Ongoing Trials on Maropitant at Clinical Trials.gov Trial results on Maropitant Clinical Trials on Maropitant at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Maropitant NICE Guidance on Maropitant NHS PRODIGY Guidance FDA on Maropitant CDC on Maropitant
Books
Books on Maropitant
News
Maropitant in the news Be alerted to news on Maropitant News trends on Maropitant
Commentary
Blogs on Maropitant
Definitions
Definitions of Maropitant
Patient Resources / Community
Patient resources on Maropitant Discussion groups on Maropitant Patient Handouts on Maropitant Directions to Hospitals Treating Maropitant Risk calculators and risk factors for Maropitant
Healthcare Provider Resources
Symptoms of Maropitant Causes & Risk Factors for Maropitant Diagnostic studies for Maropitant Treatment of Maropitant
Continuing Medical Education (CME)
CME Programs on Maropitant
International
Maropitant en Espanol Maropitant en Francais
Business
Maropitant in the Marketplace Patents on Maropitant
Experimental / Informatics
List of terms related to Maropitant

Maropitant
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral, subcutaneous
ATCvet code	Template:Infobox drug/formatATCvet; Template:Infobox drug/formatATCvet;
Legal status
Legal status	Veterinary use only;
Identifiers
	IUPAC name (7R,8S)-N-[(5-tert-Butyl-2-methoxyphenyl)methyl]-7-[di(phenyl)methyl]-1-azabicyclo[2.2.2]octan-8-amine;
PubChem CID	23724948;
ChemSpider	176804 ;
UNII	4XE2T9H4DH;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C32H40N2O
Molar mass	468.67 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C(O)C(O)(CC(=O)O)CC(=O)O.O.O(c1ccc(cc1CN[C@@H]2[C@@H](N3CCC2CC3)C(c4ccccc4)c5ccccc5)C(C)(C)C)C;
	InChI InChI=1S/C32H40N2O.C6H8O7.H2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24;7-3(8)1-6(13,5(11)12)2-4(9)10;/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);1H2/t30-,31-;;/m0../s1 ; Key:PGVSXRHFXJOMGW-YBZGWEFGSA-N ;
(verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Maropitant (trade name Cerenia in the US and other countries), used as maropitant citrate (USAN), is a neurokinin (NK₁) receptor antagonist, which was developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007 for use in dogs,^[1]^[2] and more recently has also been approved for use in cats.^[3]

Maropitant also has anti-nociceptive (analgesic) properties. In a 2012 study, parenteral maropitant decreased the minimum alveolar concentration (MAC) of sevoflurane in a pain-response model.^{[citation needed]} Epidural administration had no effect. It has also been shown to decrease the MAC of sevoflurane in a cat spay and dog spay model. Whether it has analgesic properties in awake animals remains to be proven, but anecdotal evidence indicates that it is being used for analgesia by many veterinarians.

References

External links

Cerenia: Official Page
Cerenia: Product Information at Vet Label
FDA: Adverse Drug Experience (ADE) Reports: See Maropitant (multiple sections, p. 121-152)
Boscan P, Monnet E, Mama K; et al. (2011). "Maropitant an NK-1 Antagonist Decreases the Anesthetic Requirements During Visceral Stimulation of the Ovary in Dogs". Am J Vet Res. 72: 1576–1579.
Boscan P, Monnet E, Mama K; et al. (2011). "A dog model to study ovary, ovarian ligament and visceral pain". Veterinary Anesthesia and Analgesia. 38: 260–266.
Niyom S, Boscan P, Twedt DC; et al. (2013). "Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats". Vet Anaesth Analg. 40: 425–431.

Template:Antiemetics and antinauseants Template:Neuropeptide agonists and antagonists

[urlwww.fda.gov-1] "Cerenia (maropitant citrate) Injectable Solution, Dogs" (pdf). Retrieved 2011-04-19.

[2] Package Insert for Cerenia at Pfizer Animal Health (full detailed drug information)

[3] "Cerenia (maropitant citrate) information at Pfizer Animal Health".

[1]

[2]

[3]

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Oral, subcutaneous
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Legal status
Legal status	Veterinary use only
Identifiers
IUPAC name (7R,8S)-N-[(5-tert-Butyl-2-methoxyphenyl)methyl]-7-[di(phenyl)methyl]-1-azabicyclo[2.2.2]octan-8-amine
PubChem CID	23724948
ChemSpider	176804^Y
UNII	4XE2T9H4DH
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₂H₄₀N₂O
Molar mass	468.67 g/mol
3D model (JSmol)	Interactive image
SMILES O=C(O)C(O)(CC(=O)O)CC(=O)O.O.O(c1ccc(cc1CN[C@@H]2[C@@H](N3CCC2CC3)C(c4ccccc4)c5ccccc5)C(C)(C)C)C
InChI InChI=1S/C32H40N2O.C6H8O7.H2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24;7-3(8)1-6(13,5(11)12)2-4(9)10;/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);1H2/t30-,31-;;/m0../s1^Y Key:PGVSXRHFXJOMGW-YBZGWEFGSA-N^Y
(verify)

Maropitant

Overview

References

External links

Navigation menu